Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efaproxiral with Chemoradiation in Locally Advanced NSCLC
NCT00004202Phase 2Completed
- Sponsor
- Spectrum Pharmaceuticals, Inc.
- Start
- Oct 1998
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of efaproxiral in non-small cell lung cancer (NSCLC), sponsored by Spectrum Pharmaceuticals, Inc.. Started Oct 1998; status: completed.
02
Drugs
efaproxiral
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00004202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004202.